Ted K. Yanagihara

630 total citations
36 papers, 408 citations indexed

About

Ted K. Yanagihara is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Ted K. Yanagihara has authored 36 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 10 papers in Oncology. Recurrent topics in Ted K. Yanagihara's work include Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Ted K. Yanagihara is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Brain Metastases and Treatment (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Ted K. Yanagihara collaborates with scholars based in United States, South Korea and United Kingdom. Ted K. Yanagihara's co-authors include Joy Hirsch, Peter Freed, J. John Mann, Tony J. C. Wang, David L. Perez, Daniela D. Pollak, M.T. Rogan, Tobias Egner, Raymond Y. Huang and Spiro P. Pantazatos and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Radiology.

In The Last Decade

Ted K. Yanagihara

32 papers receiving 403 citations

Peers

Countries citing papers authored by Ted K. Yanagihara

Since Specialization

Citations

This map shows the geographic impact of Ted K. Yanagihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted K. Yanagihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted K. Yanagihara more than expected).

Fields of papers citing papers by Ted K. Yanagihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted K. Yanagihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted K. Yanagihara. The network helps show where Ted K. Yanagihara may publish in the future.

Co-authorship network of co-authors of Ted K. Yanagihara

This figure shows the co-authorship network connecting the top 25 collaborators of Ted K. Yanagihara. A scholar is included among the top collaborators of Ted K. Yanagihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted K. Yanagihara. Ted K. Yanagihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma 2025 ·The American Journal of Gastroenterology ·Andrew M. Moon, (unknown), (unknown), Sasha Deutsch‐Link, Louise M. Henderson, Hanna K. Sanoff, Ted K. Yanagihara, Nima Kokabi, David Mauro, A. Sidney Barritt	0
2	1477P Overall survival among 4913 patients with hepatocellular carcinoma treated with external beam radiation therapy: Individual patient data outcomes from a multinational cohort 2025 ·Annals of Oncology ·María Reig, Andrew M. Moon, Ted K. Yanagihara, Laura A. Dawson, (unknown), Theodore S. Lawrence, Tae Hyun Kim, Michael Yan, Hiromitsu Iwata, Nima Nabavizadeh, Smith Apisarnthanarax, (unknown), M.T.W.T. Lock, Michael D. Chuong, (unknown), Marta Scorsetti, Norito Katoh, (unknown), Kazushi Numata, Ferràn Torres	1
3	Advances in radiation therapy for HCC: Integration with liver-directed treatments 2025 ·Hepatology Communications ·(unknown), Nancy Newman, Mark Yarchoan, Atoosa Rabiee, Bradford J. Wood, Riad Salem, Jonathan M. Hernandez, (unknown), Ted K. Yanagihara, Freddy E. Escorcia	1
4	Trends in the use of immunotherapy to treat soft tissue sarcoma 2024 ·The American Journal of Surgery ·Yoshiko Iwai, (unknown), (unknown), (unknown), Ted K. Yanagihara, (unknown), (unknown), Philip M. Spanheimer	1
5	Oncologic outcomes and rates of hepatotoxicity following stereotactic body radiotherapy for hepatocellular carcinoma 2024 ·Hepatoma Research ·(unknown), Michael B. Young, Xianming Tan, (unknown), (unknown), Hannah P. Kim, (unknown), Andrew M. Moon, Joel E. Tepper, Ted K. Yanagihara	1
6	Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma 2024 ·Journal of Hepatocellular Carcinoma ·(unknown), Andrew M. Moon, Michael B. Young, Xianming Tan, (unknown), (unknown), Joel E. Tepper, Ted K. Yanagihara	3
7	Outcomes of surgical resection and intraoperative electron radiotherapy for patients with para-aortic recurrences of gastrointestinal and gynecologic malignancies 2023 ·Radiation Oncology ·(unknown), (unknown), (unknown), Ted K. Yanagihara, Joel E. Tepper, Benjamin F. Calvo, Andrew Z. Wang, Kevin A. Pearlstein, Kyle Wang, Han Jo Kim	1
8	Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non–Small Cell Lung Cancer 2020 ·Radiology ·Minjae Kim, Chong Hyun Suh, Sang Min Lee, Ho Cheol Kim, Ayal A. Aizer, Ted K. Yanagihara, Harrison X. Bai, Jeffrey P. Guenette, Raymond Y. Huang, Ho Sung Kim	20
9	Practical Challenges of Mask-to-Mask Encounters with Patients with Head and Neck Cancers amid the Coronavirus Disease 2019 Pandemic 2020 ·Advances in Radiation Oncology ·Ted K. Yanagihara, (unknown), Bhisham Chera	5
10	Challenging AJCC 8 Staging for Soft Tissue Sarcoma Using the NCDB 2019 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Ted K. Yanagihara, A. Guirguis, Hani Ashamalla	4
11	Functional connectivity of PAG with core limbic system and laryngeal cortico-motor structures during human phonation 2018 ·Brain Research ·(unknown), Spiro P. Pantazatos, Kachina Allen, Ted K. Yanagihara, Joy Hirsch	4
12	Quantitative Analysis of the Spatial Distribution of Metastatic Brain Lesions 2017 ·Tomography ·Ted K. Yanagihara, Albert Lee, Tony J. C. Wang	14
13	A Simple Automated Method for Detecting Recurrence in High-Grade Glioma 2016 ·American Journal of Neuroradiology ·Ted K. Yanagihara, Jack Grinband, Jared Rowley, Keith A. Cauley, (unknown), (unknown), (unknown), Alice Chu, Tony J. C. Wang	4
14	Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma 2015 ·World Neurosurgery ·Krishna Surapaneni, Benjamin C. Kennedy, Ted K. Yanagihara, Robert L. DeLaPaz, Jeffrey N. Bruce	4
15	Frontal–Occipital Connectivity During Visual Search 2012 ·Brain Connectivity ·Spiro P. Pantazatos, Ted K. Yanagihara, Xian Zhang, Thomas J. Meitzler, Joy Hirsch	27
16	Statistical Power in Quantitative Diffusion MRI of Tumor Response 2011 ·Academic Radiology ·Ted K. Yanagihara, Benjamin C. Kennedy, Krishna Surapaneni, Jeffrey N. Bruce	1
17	A translational bridge between mouse and human models of learned safety 2010 ·Annals of Medicine ·Daniela D. Pollak, M.T. Rogan, Tobias Egner, David L. Perez, Ted K. Yanagihara, Joy Hirsch	47
18	Analysis of clamping versus cutting of T3 sympathetic nerve for severe palmar hyperhidrosis 2010 ·Journal of Thoracic and Cardiovascular Surgery ·Ted K. Yanagihara, Ali N. Ibrahimiye, Catherine R. Harris, Joy Hirsch, Lyall A. Gorenstein	19
19	Neural Mechanisms of Grief Regulation 2009 ·Biological Psychiatry ·Peter Freed, Ted K. Yanagihara, Joy Hirsch, J. John Mann	69
20	Prolonged Positive Modulation of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Induces Calpain-Mediated PSD-95/Dlg/ZO-1 Protein Degradation and AMPA Receptor Down-Regulation in Cultured Hippocampal Slices 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Hussam Jourdi, Xiaoying Lü, Ted K. Yanagihara, Julie C. Lauterborn, Xiaoning Bi, Christine M. Gall, Michel Baudry	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact